On June 3rd, component stock Structure Therapeutics ADR is currently up 41.08%, leading the way. Olema is up 22.47%, while MacroGenics, Precigen, Agios Pharmaceuticals, Novavax, Relay Therapeutics Inc., Intellia Therapeutics, Taysha Gene, and Pacific Biosciences of California are up 19.78% to 11.45%, and Morphic Holding, Revance Therapeutics, Bluebird Bio, Arrowhead Pharmaceuticals are up 10.93% to 10.30%, and RAPT Therapeutics is also up 9.98%; Sarepta Therapeutics is down 3.80%, Immunocore Holdings is down 10.11%, Alx Oncology Holdings is down 12.42%, and Caribou Biosciences is also down 25.52%.
纳斯达克生物科技指数上涨将近2.4%
The NASDAQ Biotechnology Index has risen nearly 2.4%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.